Dual effects of sodium aescinate on vascular tension in rat thoracic aorta. 2010

Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
Department of Neurology, The First Affiliated Hospital, College of Medicine, Zhejiang University, PR China.

OBJECTIVE Sodium aescinate (SA) is used as a vasoactive drug in clinical treatment. This study was designed to investigate the effects of SA on rat isolated thoracic aorta and the possible mechanisms. METHODS Isometric tension was recorded in response to drugs in organ bath. RESULTS The effects of SA obeyed an all-or-nothing response. SA in relatively low dose (> or = 50 microg/ml) had an endothelium-independent contractile effect in rat aorta (P<0.01), which depended on extracellular Ca(2+) influx via L-type Ca(2+) channel (P<0.05). SA in relatively high dose (> or = 100 microg/ml) also induced vasoconstriction in Ca(2+)-free medium (P<0.01), which was independent of the activity of inositol-1,4,5-trisphosphate receptor (IP(3)R), ryanodine receptor (RYR), and protein kinase C (PKC). SA in relatively high dose (> or = 100 microg/ml) dilated both endothelium-intact and endothelium-denuded aortic rings precontracted by phenylephrine (PE) or KCl (each P<0.01). SA inhibited extracellular Ca(2+) influx induced by PE or KCl (each P<0.01) and had no activation effect on K(+) channels on vascular smooth muscle. The relaxant effect of SA partly depended on the activity of NO synthase but not on the activity of cyclooxygenase. CONCLUSIONS Taken together, this study indicated that SA had dual effects on vascular tension in rat isolated thoracic aorta.

UI MeSH Term Description Entries
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004928 Escin Pentacyclic triterpene saponins, biosynthesized from protoaescigenin and barringtogenol, occurring in the seeds of AESCULUS. It inhibits edema formation and decreases vascular fragility. Aescin,Aescusan,Escina,Eskuzan,Fepalitan,Feparil,Flebostasin,Opino,Reparil,beta-Aescin,beta-Escin,opino-biomo,beta Aescin,beta Escin,opino biomo,opinobiomo
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
October 2002, Life sciences,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
December 2003, Life sciences,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
May 2003, Life sciences,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
August 2005, Biological & pharmaceutical bulletin,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
March 2006, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
January 1980, Artery,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
January 2003, Vascular pharmacology,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
September 1990, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
January 2017, Bratislavske lekarske listy,
Xia Li, and Guo-Ping Chen, and Liang Li, and Kai-Jun Wang, and Bi-Qi Zhang, and Shen-Jiang Hu
August 2022, Annals of vascular surgery,
Copied contents to your clipboard!